This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fondazione Telethon. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Ivan Conte: Innovator in Retinal Dystrophy Treatment
Introduction
Ivan Conte is a notable inventor based in Naples, Italy. He has made significant contributions to the field of medical research, particularly in the treatment of retinal dystrophies. His innovative work focuses on the use of microRNAs to combat photoreceptor degeneration.
Latest Patents
Ivan Conte holds a patent for "MiR-204 and miR-211 and uses thereof." This invention relates to an agent capable of increasing the level of one or more microRNAs in the cells of a subject. The specific microRNA sequence involved is UUCCCUU, which is utilized for the treatment and prevention of retinal dystrophy. This invention includes relative pharmaceutical compositions, nucleic acids, vectors, and host cells.
Career Highlights
Ivan Conte is associated with Fondazione Telethon, an organization dedicated to funding research for genetic diseases. His work at this foundation has allowed him to focus on groundbreaking research that aims to improve the lives of individuals suffering from retinal conditions.
Collaborations
Ivan has collaborated with esteemed colleagues such as Sandro Banfi and Enrico Maria Surace. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Ivan Conte's contributions to the field of retinal dystrophy treatment through his patent and collaborative efforts highlight his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of genetic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile